ATE128862T1 - Zusammensetzung zur lokalen anwendung. - Google Patents

Zusammensetzung zur lokalen anwendung.

Info

Publication number
ATE128862T1
ATE128862T1 AT91920206T AT91920206T ATE128862T1 AT E128862 T1 ATE128862 T1 AT E128862T1 AT 91920206 T AT91920206 T AT 91920206T AT 91920206 T AT91920206 T AT 91920206T AT E128862 T1 ATE128862 T1 AT E128862T1
Authority
AT
Austria
Prior art keywords
composition
topical use
liquid phases
application
human
Prior art date
Application number
AT91920206T
Other languages
English (en)
Inventor
Adrian Francis Davis
Brands Consumer
Jennifer Jane Gordon
Original Assignee
Beecham Group Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Beecham Group Plc filed Critical Beecham Group Plc
Application granted granted Critical
Publication of ATE128862T1 publication Critical patent/ATE128862T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Dermatology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AT91920206T 1990-11-27 1991-11-21 Zusammensetzung zur lokalen anwendung. ATE128862T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB909025711A GB9025711D0 (en) 1990-11-27 1990-11-27 Topical composition

Publications (1)

Publication Number Publication Date
ATE128862T1 true ATE128862T1 (de) 1995-10-15

Family

ID=10686018

Family Applications (1)

Application Number Title Priority Date Filing Date
AT91920206T ATE128862T1 (de) 1990-11-27 1991-11-21 Zusammensetzung zur lokalen anwendung.

Country Status (19)

Country Link
EP (1) EP0559682B1 (de)
JP (1) JPH06502856A (de)
KR (1) KR100218652B1 (de)
AT (1) ATE128862T1 (de)
AU (1) AU661283B2 (de)
CA (1) CA2096963C (de)
DE (1) DE69113811T2 (de)
DK (1) DK0559682T3 (de)
ES (1) ES2079687T3 (de)
GB (1) GB9025711D0 (de)
GR (1) GR3018613T3 (de)
HK (1) HK1006279A1 (de)
IE (1) IE68953B1 (de)
MY (1) MY108692A (de)
NZ (1) NZ240707A (de)
PT (1) PT99608B (de)
SA (1) SA92120308B1 (de)
WO (1) WO1992009266A1 (de)
ZA (1) ZA919289B (de)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9125712D0 (en) * 1991-12-03 1992-01-29 Smithkline Beecham Plc Skin care composition
GB9207988D0 (en) * 1992-04-10 1992-05-27 Smithkline Beecham Plc Topical composition
US5464610A (en) * 1992-10-15 1995-11-07 Schering-Plough Healthcare Products, Inc. Method for treating onychomycosis
US5484606A (en) * 1994-01-24 1996-01-16 The Procter & Gamble Company Process for reducing the precipitation of difficulty soluble pharmaceutical actives
US6019988A (en) * 1996-11-18 2000-02-01 Bristol-Myers Squibb Company Methods and compositions for enhancing skin permeation of drugs using permeation enhancers, when drugs and/or permeation enhancers are unstable in combination during long-term storage
FR2771634B1 (fr) * 1997-12-02 2000-04-28 Jean Pierre Benoit Produit d'hygiene capillaire et/ou corporelle pour les hommes et les animaux et procede pour sa fabrication
US6649174B2 (en) 1998-05-07 2003-11-18 E-L Management Corp. Dual phase cosmetic composition
US6524623B1 (en) * 1999-11-12 2003-02-25 Milton Hodosh Therapeutic compositions and methods of use thereof
DE10235422A1 (de) * 2002-08-02 2004-02-12 Beiersdorf Ag Kosmetische Zubereitungen mit zwei Phasen

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8319540D0 (en) * 1983-07-20 1983-08-24 Bovril Ltd Amine removal
GB8401965D0 (en) * 1984-01-25 1984-02-29 Beecham Group Plc Composition
GB8629639D0 (en) * 1986-12-11 1987-01-21 Beecham Group Plc Composition & method

Also Published As

Publication number Publication date
IE914090A1 (en) 1992-06-03
AU661283B2 (en) 1995-07-20
JPH06502856A (ja) 1994-03-31
KR100218652B1 (ko) 1999-09-01
GB9025711D0 (en) 1991-01-09
KR930702958A (ko) 1993-11-29
IE68953B1 (en) 1996-07-24
DE69113811T2 (de) 1996-04-11
WO1992009266A1 (en) 1992-06-11
PT99608B (pt) 1999-05-31
MY108692A (en) 1996-10-31
PT99608A (pt) 1992-11-30
ES2079687T3 (es) 1996-01-16
CA2096963A1 (en) 1992-05-28
GR3018613T3 (en) 1996-04-30
EP0559682A1 (de) 1993-09-15
HK1006279A1 (en) 1999-02-19
CA2096963C (en) 2002-04-30
EP0559682B1 (de) 1995-10-11
NZ240707A (en) 1994-02-25
AU8929591A (en) 1992-06-25
DK0559682T3 (da) 1995-12-04
ZA919289B (en) 1992-10-28
SA92120308B1 (ar) 2005-06-15
DE69113811D1 (de) 1995-11-16

Similar Documents

Publication Publication Date Title
FI883055A7 (fi) Deodoroiva ja antimikrobinen koostumus käytettäväksi kosmeettisissa tai paikallisesti käytettävissä valmisteissa.
ATE424418T1 (de) Kohlenhydratbindungsdomäne enthaltende fusionsproteine zur verabreichung von therapeutischen und anderen stoffen und zusammensetzungen in denen die fusionsproteine enthalten sind
FI20115742L (fi) Mometasonifuroaatin käyttö lääkkeen valmistuksessa
BG103552A (bg) Терапевтични средства
DE69535684D1 (de) Zusammensetzungen welche DNA zerstoerende Agentien und P53 enthalten
DE69512685D1 (de) Mittel zur verabreichung von wirksubstanzen an bzw. durch die haut
CY2007001I1 (el) Φαρμακευτικο σκευασμα για χρηση στη θεραπεια του διαβητη
BR9403783A (pt) Uso de uma composição cosmética
MX9102353A (es) N,o-sulfados de heparosanos, su procedimiento de preparacion y las composiciones farmaceuticas que contienen.
SE8504945L (sv) Farmaceutiska kompositioner innehallande antracyklinglykosider
FI972286L (fi) Uudella tavalla substituoituja DTPA-johdoksia, niiden metallikomplekseja, kyseisiä komplekseja sisältäviä farmaseuttisia aineita ja niiden käyttö diagnosoinnissa ja terapiassa
DE69301356D1 (de) Übersättigte topische zusammensetzungen
FI863971A7 (fi) Farmaseuttinen koostumus käytettäväksi leukopenian hoidossa.
DE69113811D1 (de) Zusammensetzung zur lokalen anwendung.
KR940018087A (ko) 진통제 및 소염제로서의 6-클로로-5-플루오로-3-(2-테노일)-2-옥신돌-ⅰ-카복스아미드
DE3582594D1 (de) Proglumid und dessen pharmazeutische zusammensetzungen zur anwendung bei der behandlung von neoplastischen affektionen.
ITMI942663A0 (it) Proteine ricche in idrossiprolina e formulazioni farmaceutiche e cosmetiche che le compongono
FR2781154B1 (fr) Composition therapeutique a base d'isoflavonoides destinee a etre utilisee dans le traitement des tumeurs par des agents cytotoxiques
FI945694L (fi) Substituoiden triatsolin sulfaattisuola, sen farmaseuttisia koostumuksia ja niiden käyttö terapiassa
FR2781153B1 (fr) Composition therapeutique a base de flavonoides destinee a etre utilisee dans le traitement des tumeurs par des agents cytotoxiques
FI956353L (fi) Farmaseuttiset valmisteet ja niiden käyttö etenkin neurodegeneratiivisten sairauksien hoidossa
FR2804601B1 (fr) Dispositif d'application de principes actifs utilisables dans le domaine pharmaceutique ou cosmetique
DK0487713T3 (da) Flydende biologisk lim
DE69626401D1 (de) Arzneimittel zur topischen anwendung
MX9100886A (es) Activador de plasminogeno hibrido,procedimiento para su preparacion y composiciones farmaceuticas que lo contienen

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee